Epigenomics AG (FRA:ECX)
Germany
· Delayed Price · Currency is EUR 0.8900
+0.0100 (1.14%)
At close: Aug 12, 2025, 10:00 PM CET
Epigenomics AG Revenue
Epigenomics AG had revenue of 4.00K EUR in the half year ending June 30, 2025, a decrease of -98.03%. This brings the company's revenue in the last twelve months to 4.00K, down -97.06% year-over-year.
Revenue (ttm)
4.00K
Revenue Growth
-97.06%
P/S Ratio
195.12
Revenue / Employee
1.33K
Employees
2
Market Cap
780.49K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 339.00K | -560.00K | -62.29% |
| Dec 31, 2022 | 899.00K | -5.30M | -85.51% |
| Dec 31, 2021 | 6.20M | 5.36M | 636.70% |
| Dec 31, 2020 | 842.00K | -283.00K | -25.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 78.30B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 123.69B |
| Siemens Energy AG | 38.39B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Rheinmetall AG | 10.67B |
| Deutsche Bank Aktiengesellschaft | 30.07B |